Noninvasive evaluation of hepatic fibrosis in children with infant hepatitis syndrome

Table 3 Serum fibrosis indexes in patients with different fibrosis stage of IHS (mean ± SD, μg/L)

Group	Patients (n)	HA	PC- III	C IV	LN
Control group	46	225.18 ± 80.58	432.32 ± 166.68	129.69 ± 33.08	141.63 ± 34.63
Mild group	12	352.11 ± 157.33a	445.73 ± 191.11	149.85 ± 49.27	151.22 ± 36.57
Moderate group	12	447.48 ± 175.57b	480.77 ± 217.15	141.91 ± 47.51	132.56 ± 41.29
Severe group	15	745.32 ± 231.12bd	580.36 ± 147.79 a	185.00 ± 45.82b	167.90 ± 29.41a

HA, Serum hyaluronic acid; PC- III: Pre-Collagen type III; C-IV: Collagen type IV; LN: Laminin.

^aP < 0.05, and

^bP < 0.01 vs control group;

^dP < 0.01, vs mild and moderate group.